85128-6-RR
antibody from Proteintech Group
Targeting: FOXP3
AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 85128-6-RR - Provider product page

- Provider
- Proteintech Group
- Product name
- Foxp3 monoclonal antibody
- Antibody type
- Recombinant
- Description
- Foxp3 monoclonal antibody (Catalog no. 85128-6-RR) is a rabbit recombinant antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB, IHC, IF-P, IF-Fro, ELISA
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 242853G11
Submitted references Effect of Chang'an decoction on ulcerative colitis by regulating T helper 17 cells and regulatory T cellsRab27 in the p53/high mobility group box 1 pathway.
Pterostilbene as a pyroptosis inducer and tumor microenvironment regulator inhibits glioblastoma and enhances the efficacy of immunotherapy.
The role of substance P in Th17/Treg imbalance and ocular surface damage in chronic allergic conjunctivitis.
Li Z, Ting J, Xiaojing W, Yingqi W, Fengbin L, Hong MI
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 2025 Oct;45(5):998-1008
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 2025 Oct;45(5):998-1008
Pterostilbene as a pyroptosis inducer and tumor microenvironment regulator inhibits glioblastoma and enhances the efficacy of immunotherapy.
Chen Z, Fang XG, Jia LJ, Feng Y, Cheng JH, Luo S, Wen S, Wei JR, Ma SN, Guo XR, Luo J
International immunopharmacology 2025 Oct 10;163:115247
International immunopharmacology 2025 Oct 10;163:115247
The role of substance P in Th17/Treg imbalance and ocular surface damage in chronic allergic conjunctivitis.
Bao J, Wen Y, Wu B, Li Y, Li S, Lei F, Tian L, Chen X, Jie Y
Journal of translational medicine 2025 Dec 1;23(1):1367
Journal of translational medicine 2025 Dec 1;23(1):1367
No comments: Submit comment
No validations: Submit validation data